On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...